|
C12ORF65 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
8.00360000000611E-05 |
| Normal-vs-Stage3 |
8.91939999636548E-08 |
| Normal-vs-Stage4 |
2.767900E-04 |
| Stage1-vs-Stage2 |
2.807200E-01 |
| Stage1-vs-Stage3 |
1.285580E-01 |
| Stage1-vs-Stage4 |
2.116800E-01 |
| Stage2-vs-Stage3 |
4.928200E-02 |
| Stage2-vs-Stage4 |
4.450300E-02 |
| Stage3-vs-Stage4 |
8.449600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.35229605291443E-11 |
| Normal-vs-Asian |
4.540500E-02 |
| Caucasian-vs-AfricanAmerican |
6.874000E-01 |
| Caucasian-vs-Asian |
6.847200E-01 |
| AfricanAmerican-vs-Asian |
5.933000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.4432899320127E-15 |
| Male-vs-Female |
6.161400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.67960045450411E-10 |
| Normal-vs-Extreme_Weight |
1.64968039229052E-12 |
| Normal-vs-Obese |
2.36921593455008E-13 |
| Normal-vs-Extreme_Obese |
1.799340E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.462200E-01 |
| Normal_Weight-vs-Obese |
1.532980E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.401400E-01 |
| Extreme_Weight-vs-Obese |
3.055200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.122400E-01 |
| Obese-vs-Extreme_Obese |
6.900200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.31110000001211E-06 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64657176782157E-12 |
| Normal-vs-Age(81-100Yrs) |
3.783100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.887000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.237900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.719400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.482400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.033600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.899800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
7.53229999483906E-08 |
| Normal-VS-KIRP CIMP |
5.41359956862664E-10 |
| Normal-VS-Unclassified PRCC |
1.79110000053662E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.185960E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.988000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.413600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.778040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.290000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.431600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13319995001626E-09 |
| Normal-vs-N1 |
1.74800000030118E-08 |
| Normal-vs-N2 |
6.52360000019669E-07 |
| N0-vs-N1 |
1.530080E-02 |
| N0-vs-N2 |
3.977600E-01 |
| N1-vs-N2 |
7.298000E-01 |
|
|
